Patents
Patents for C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
02/2015
02/10/2015US8952120 Polyisocyanate composition and coating composition containing the same
01/2015
01/13/2015US8933065 N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
12/2014
12/30/2014US8921571 Pyrrolysine analogs
10/2014
10/30/2014US20140323457 Beta-o/s/n fatty acid based compounds as antibacterial and antiprotozoal agents
10/21/2014US8865898 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
09/2014
09/09/2014US8829033 N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
08/2014
08/21/2014WO2014127350A1 Modulators of vasopressin receptors with therapeutic potential
08/06/2014CN102942525B 一种制备含脲二酮基团的多异氰酸酯的方法 A method polyisocyanate containing uretdione groups prepared
06/2014
06/12/2014US20140162996 Novel modulators of development of adipocyte and cancer cells
06/10/2014US8748411 Antineoplastic compounds and pharmaceutical compositions thereof
06/03/2014US8742110 Spiroxazolidinone compounds
05/2014
05/21/2014CN103804297A 用于制备mdi二聚体的方法 Methods for preparing dimers mdi
05/20/2014US8729259 Method for producing 1:1 adducts having a low monomer content from hydroxyalkyl(meth)acrylates and diisocyanates
05/15/2014US20140135458 Method for the production of mdi dimer
05/14/2014EP2730563A1 Process for the preparation of MDI dimer
04/2014
04/30/2014EP2725014A1 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino] heptanoic acid S,S dioxide and methods of making and using the same
04/30/2014CN102257026B Method for producing colourless polyisocyanates
03/2014
03/27/2014US20140088063 Agents for treating neurodegenerative disorders
03/05/2014CN103613540A Method for preparing urethodione group-containing diisocyanate homopolymer
02/2014
02/27/2014WO2013186153A3 Amidophenoxypropanolamines
02/20/2014WO2014027964A1 Universal biosensing and bioassay devices
01/2014
01/29/2014CN101450928B Production of uretdione polyisocyanates
12/2013
12/19/2013WO2013186153A2 Amidophenoxypropanolamines
12/04/2013EP2552894B1 Method to produce uretonimine-modified isocyanate composition
10/2013
10/31/2013WO2013121334A3 Agents for treating neurodegenerative disorders
10/31/2013WO2013111118A3 Diaziridines for treating neurodegenerative disorders
10/31/2013WO2013111117A3 Diaziridines for treating neurodegenerative disorders
10/09/2013EP2647617A1 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
08/2013
08/22/2013WO2013121334A2 Agents for treating neurodegenerative disorders
08/13/2013CA2509861C Improved process for the production of carbodiimide modified organic isocyanates
08/07/2013EP2621906A1 Diazaridine derivatives for treating metal disorders
08/07/2013CN103237780A Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-cid probe for detecting gene
06/2013
06/19/2013CN101356153B Method for producing liquid, storage-stable organic isocyanates comprising carbodiimide and/or uretonimine groups
06/05/2013EP2598661A2 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
06/05/2013EP2598660A2 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
04/2013
04/23/2013US8426449 Aminoalkylphenyl antagonists of prostaglandin D2 receptors
02/2013
02/27/2013CN102942525A Method for preparing polyisocyanate containing uretidione group
02/13/2013CN102933554A Crosslinking reagents, methods, and compositions for studying protein-protein interactions
02/06/2013EP2552894A1 Method to produce uretonimine-modified isocyanate composition
01/2013
01/10/2013US20130012698 Method to produce uretonimine-modified isocyanate composition
01/02/2013CN102858747A Method to produce uretonimine-modified isocyanate composition
12/2012
12/20/2012US20120322978 Crosslinking reagents, methods, and compositions for studying protein-protein interactions
10/2012
10/24/2012CN102746230A Method for synthesis of 3-(3-methoxyphenyl)-3-trifluoromethyl-3H-diazirine
09/2012
09/13/2012US20120232015 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
09/13/2012US20120231376 Fluorourethane as an additive in a photopolymer formulation
08/2012
08/28/2012US8252781 1,2-diazetidin-3-one derivatives and drugs containing same
08/14/2012US8242145 Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors
08/09/2012WO2012018638A3 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
07/2012
07/05/2012WO2012018639A3 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
06/2012
06/07/2012WO2012074012A1 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
06/06/2012CN101289427B Preparation of polyisocyanates containing uretdione groups using phosphine catalysts
05/2012
05/09/2012CN102442959A Process for preparation of polyisocyanates and use thereof
05/02/2012CN102432931A New aqueous resorcinol-formaldehyde-latex dispersions, process for their production and their use
04/2012
04/05/2012WO2012042502A1 Diazaridine derivatives for treating metal disorders
04/03/2012CA2491459C Polyadducts containing uretdione groups
03/2012
03/29/2012US20120073472 Reactive derivatives on the basis of dianhydrohexitol-based isocyanates
02/2012
02/09/2012WO2012018639A2 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
02/09/2012WO2012018638A2 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
02/09/2012CA2806734A1 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
02/09/2012CA2806670A1 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
01/2012
01/26/2012WO2011109326A3 Crosslinking reagents, methods, and compositions for studying protein-protein interactions
12/2011
12/27/2011US8084617 Ionic liquids having fluoroalkyltrifluoroborate anions
12/08/2011US20110301345 Method for producing 1:1 adducts having a low monomer content from hydroxyalkyl(meth)acrylates and diisocyanates
11/2011
11/23/2011CN102257026A Method for producing colourless polyisocyanates
11/15/2011US8058382 Uretdione formation in solution
11/15/2011CA2488071C Preparation of polyisocyanates containing uretdione groups
10/2011
10/25/2011US8043666 A photoreactive compound having a diazirine group such as 3-(epoxy)phenyl),3-trifluoromethyl-3H-diazirine to modify polyamines such as polytriethylenediamine; immobilized coating on a polypropylene sheet to further react with DNA or proteins to prepare biological chips for testing
10/18/2011US8039574 Method for the preparation of low-viscosity (poly) isocyanates
10/18/2011CA2491050C Isocyanates containing uretdione groups
10/06/2011WO2011120750A1 Method to produce uretonimine-modified isocyanate composition
10/06/2011CA2789185A1 Method to produce uretonimine-modified isocyanate composition
09/2011
09/20/2011US8022200 Process for the preparation of liquid, storage-stable organic isocyanates of low color number containing carbodiimide and/or uretonimine groups
09/07/2011CN101356208B Method for producing liquid, storage-stable organic isocyanates comprising carbodiimide and/or uretonimine groups
08/2011
08/31/2011EP1509492B1 Short-acting sedative hypnotic agents for anesthesia and sedation
08/31/2011EP1270642B1 Branched polyalkylene glycols
07/2011
07/27/2011EP2348019A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
07/20/2011EP2344563A1 Method for producing colourless polyisocyanates
05/2011
05/10/2011US7939689 Short-acting sedative hypnotic agents for anesthesia and sedation
04/2011
04/26/2011CA2446778C Process for preparing polyisocyanates
03/2011
03/15/2011CA2474262C Short-acting sedative hypnotic agents for anesthesia and sedation
01/2011
01/25/2011CA2450453C Preparation of polyisocyanates containing uretdione groups
01/19/2011CN101003499B Novel color former and recording material
10/2010
10/19/2010CA2446775C Process for preparing aliphatic polyisocyanates having uretdione, isocyanurate, and iminooxadiazinedione structure
10/14/2010WO2010115684A1 Method for producing oligomeric diphenylmethane-4,4'- and/or diphenylmethane-2,4'-diisocyanate-uretdiones
10/13/2010CN1502605B Preparation of polyisocyanates containing uretidione groups
09/2010
09/21/2010US7799926 novel fluorescent dyes comprising arsonate group, and oligonucleotide probes; use in fluorescence resonance energy transfer (FRET) detection; carbocyanine dyes; preparing an oligonucleotide conjugate in an automated synthesis
08/2010
08/17/2010US7777054 Reduced color via hindered amino ether; quenching; 4,4'-diphenylmethane diisocyanate (MDI) and catalyst for reaction of isocyanate groups to form carbodiimides that undergo further reaction to form uretonimine oligomers; storage stability
07/2010
07/13/2010CA2446777C Method for the dimerization of isophorone diisocyanate
07/08/2010US20100173793 Peptide / protein identification using photoreactive carriers for the immobilisation of the ligands
07/08/2010US20100172960 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
06/2010
06/10/2010US20100144694 1,2-diazetidin-3-one derivatives and drugs containing same
05/2010
05/26/2010CN1660792B Preparation of polyisocyanates containing uretdione groups with bicycloalkylphosphines
05/11/2010US7714148 partially carbodiimidizing one or more organic isocyanates in the presence phospholine catalyst, and a silylated acid amide; subsequently, terminating the carbodiimidization reaction
05/11/2010CA2395254C Branched polyalkylene glycols
05/06/2010WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
04/2010
04/29/2010WO2010046327A1 Method for producing colourless polyisocyanates
04/07/2010EP1358238B1 Catalyst for isocyanate condensation, composition containing same, method for use, and resulting compositions
04/06/2010US7691367 A therapeutic polypeptide drug conjugated with two chains of polyoxyethylene glycol, linked to a cyclohexane ring; high molecular weight, stability, nontoxic, sustained release
03/2010
03/03/2010EP2159241A1 Method for producing oligomeric diphenylmethane-4,4' and/or diphenylmethan-2,4'-diisocyanate-uretdione
01/2010
01/27/2010CN100584824C Polyisocyamic acid ester compound, preparation method of the compound, addition polymer composition and powder paint
1 2 3 4 5 6